International Clinical Trial: Multi-omics exploration of gut microbiome-host co-metabolic characteristics in inflammatory bowel disease with metabolic dysfunction-associated steatotic liver disease

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117390) titled 'Multi-omics exploration of gut microbiome-host co-metabolic characteristics in inflammatory bowel disease with metabolic dysfunction-associated steatotic liver disease' on Jan. 23.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Longhua Hospital Shanghai University of Traditional Chinese Medicine

Condition: Inflammatory bowel disease-metabolic dysfunction-associated steatotic liver disease(IBD-MASLD)

Intervention: IBD-non-MASLD group:None

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-10-20

Target Sample Size: IBD-non-MASLD group:300;IBD-MAS...